iTeos Therapeutics, Inc. ITOS NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score

51/100

2/7 Pass

SharesGrow Intrinsic Value

Il y a eu 50 transactions d'initiés récentes enregistrées pour iTeos Therapeutics, Inc. (ITOS), dont 31 achats et 14 ventes. Le total des achats d'initiés s'élève à $83.46M et le total des ventes d'initiés à $25.43M.

Les initiés notables ayant une activité récente comprennent Detheux Michel, Hallal David, Ecor1 Capital, Llc. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — ITOS

Date	Nom	Rôle	Type de Transaction	Actions	Prix Moyen	Valeur	Actions détenues
2025-06-10	Detheux Michel	Chief Executive Officer	Vente Informative	43,883	$10.02	$439.71K	-
2025-06-09	Detheux Michel	Chief Executive Officer	Vente Informative	43,882	$10.03	$440.14K	-
2025-06-06	Hallal David	Director	Exercice d'Options (Vente)	38,228	$4.30	$164.38K	-
2025-06-06	Detheux Michel	Chief Executive Officer	Vente Informative	43,882	$10.21	$448.04K	-
2025-06-05	Hallal David	Director	Vente Informative	38,227	$10.15	$388K	-
2025-06-05	Detheux Michel	Chief Executive Officer	Vente Informative	43,882	$10.15	$445.4K	-
2025-06-04	Hallal David	Director	Vente Informative	38,227	$10.07	$384.95K	-
2025-06-04	Detheux Michel	Chief Executive Officer	Vente Informative	43,883	$10.10	$443.22K	-
2025-05-15	Ecor1 Capital, Llc	10 Percent Owner	Achat Informatif	3,300,000	$8.00	$26.4M	10,688,978
2025-05-14	Ecor1 Capital, Llc	10 Percent Owner	Achat Informatif	1,658,978	$7.41	$12.29M	7,388,978
2025-05-13	Ecor1 Capital, Llc	10 Percent Owner	Inconnu	-	-	-	5,730,000
2025-05-13	Van Hauwermeiren Timothy	Director	Exercice d'Options (Vente)	22,346	$4.30	$96.09K	-
2025-05-13	Gadicke Ansbert	Other: Former 10% Owner	Vente Informative	1,031,931	$8.06	$8.32M	3,452,797
2025-05-13	Mpm Bioventures 2014, L.p.	Other: Former 10% Owner	Vente Informative	630,191	$8.06	$5.08M	2,108,594
2025-05-13	Mpm Bioventures 2018, L.p.	Other: Former 10% Owner	Vente Informative	630,191	$8.06	$5.08M	2,108,594
2025-03-07	Gall Matthew	Chief Financial Officer	Attribution de RSU	24,000	-	-	89,429
2025-03-07	Detheux Michel	Chief Executive Officer	Attribution de RSU	77,000	-	-	135,903
2025-03-07	Call Matthew	Chief Operating Officer	Attribution de RSU	145,000	$7.05	$1.02M	145,000
2025-03-07	Mcgrath Yvonne	Chief Scientific Officer	Attribution de RSU	15,300	-	-	46,300
2024-12-06	Feltquate David	Chief Medical Officer	Attribution de RSU	47,000	-	-	47,000
2024-11-19	Gall Matthew	Chief Financial Officer	Achat Informatif	5,000	$7.73	$38.64K	65,429
2024-08-08	Detheux Michel	Chief Executive Officer	Don (Donné)	442,800	$11.58	$5.13M	147,600
2024-08-01	Feltquate David	Chief Medical Officer	Attribution de RSU	350,000	$17.46	$6.11M	350,000
2024-07-31	Feltquate David	Officer	Inconnu	-	-	-	-
2024-06-11	Rhoads Ann D	Director	Attribution de RSU	24,200	$16.32	$394.94K	24,200
2024-06-11	Hallal David	Director	Attribution de RSU	24,200	$16.32	$394.94K	24,200
2024-06-11	Davis Aaron I.	Director	Attribution de RSU	24,200	$16.32	$394.94K	24,200
2024-06-11	Ho Tony W	Director	Attribution de RSU	24,200	$16.32	$394.94K	24,200
2024-06-11	Iannone Robert	Director	Attribution de RSU	24,200	$16.32	$394.94K	24,200
2024-06-11	Van Hauwermeiren Timothy	Director	Attribution de RSU	24,200	$16.32	$394.94K	24,200
2024-06-11	Desimone Jill	Director	Attribution de RSU	24,200	$16.32	$394.94K	24,200
2024-06-11	Lee David K	Director	Attribution de RSU	24,200	$16.32	$394.94K	24,200
2024-05-12	Ra Capital Management, L.p.	Other: Former 10% Owner	Autre (Vente)	900,000	-	-	2,545,510
2024-05-10	Ra Capital Management, L.p.	Other: Former 10% Owner	Achat Informatif	5,714,285	$0.00	$5.71K	5,714,285
2024-05-10	Boxer Capital, Llc	Other: See Remarks	Attribution de RSU	1,142,857	$17.50	$20M	2,946,915
2024-03-07	Desimone Jill	Officer	Inconnu	-	-	-	-
2024-03-07	Desimone Jill	Director	Attribution de RSU	44,766	$11.58	$518.39K	44,766
2024-03-07	Gall Matthew	Chief Financial Officer	Attribution de RSU	163,200	$11.58	$1.89M	163,200
2024-03-07	Detheux Michel	Chief Executive Officer	Attribution de RSU	590,400	$11.58	$6.84M	590,400
2024-03-07	Call Matthew	Chief Operating Officer	Attribution de RSU	225,000	$11.58	$2.61M	225,000
2024-03-07	Mcgrath Yvonne	Chief Scientific Officer	Attribution de RSU	153,600	$11.58	$1.78M	153,600
2023-12-05	Gall Matthew	Chief Financial Officer	Attribution de RSU	41,000	-	-	60,429
2023-12-05	Detheux Michel	Chief Executive Officer	Attribution de RSU	30,000	-	-	58,903
2023-12-05	Call Matthew	Chief Operating Officer	Attribution de RSU	44,000	-	-	137,898
2023-12-05	Mcgrath Yvonne	Chief Scientific Officer	Attribution de RSU	31,000	-	-	31,000
2023-12-05	Lee David K	Officer	Inconnu	-	-	-	-
2023-12-05	Lee David K	Director	Attribution de RSU	44,766	$9.84	$440.5K	44,766
2023-10-12	Gall Matthew	Chief Financial Officer	Achat Informatif	5,000	$8.37	$41.85K	19,429
2023-08-23	Boxer Capital, Llc	Officer	Vente Informative	219,638	$16.87	$3.71M	1,804,058
2023-06-13	Rhoads Ann D	Director	Attribution de RSU	22,383	$14.77	$330.6K	22,383

■ Informatif — transaction sur marché ouvert (la plus significative) ■ Non informatif (achat) — récompense, exercice d'option, conversion ■ Non informatif (vente) — retenue fiscale, vente à l'acquisition ■ Neutre — don, fiducie, expiration